Joanna Horobin

KYMR

Joanna Horobin serves as Director at Kymera Therapeutics, Inc. (KYMR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$416.3K

Net Position

Net Seller

$416.3K

Companies Traded

LQDA, KYMR

Active Period

Jun 2024 – Aug 2025

2 total trades

Most Recent

Sell LQDA

Aug 19, 2025 · $135.8K

Joanna Horobin's Insider Trading at Kymera Therapeutics, Inc. (KYMR)

Buys

0 · $0.00

Sells

1 · $280.4K

Total Shares Bought

Total Shares Sold

8,500

KYMR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 7, 2024	Sell	8,500	$32.99	$280.4K	6,313

Joanna Horobin's Insider Trading at Liquidia Corporation (LQDA)

Buys

0 · $0.00

Sells

1 · $135.8K

Total Shares Bought

Total Shares Sold

5,000

LQDA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2025	Sell	5,000	$27.17	$135.8K	0

Related Insiders

SINGH RAMAN

director

LQDASell · Sep 15, 2026

Brian Adams

officer: Chief Legal Officer

KYMRSell · Sep 4, 2026

Sarah Krepp

officer: Chief Human Resource Officer

LQDASell · Sep 3, 2026

Jason Adair

officer: Chief Business Officer

LQDASell · Aug 25, 2026

Katherine Rielly-Gauvin

director

LQDASell · Aug 21, 2026

Rajeev Saggar

officer: Chief Medical Officer

LQDASell · Aug 19, 2026

Dana Boyle

officer: Chief Accounting Officer

LQDASell · Jul 29, 2026

Stephen M Bloch

director

LQDASell · Jul 24, 2026

Explore More Insider Trading Data

KYMR Insider Trading Activity

View all insider trades at Kymera Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity